Dissertationen der Medizinischen Fakultät

2012

Bevier, Melanie (2012) Cancer of unknown primary: analysis of incidence trends, survival and familial risks to suggest organs to search for primary tumors.

2011

Huhn, Stefanie (2010) Ancestral Susceptibility to Colorectal Cancer.

Shi, Hong (2011) MYBL2 related Genes as Prognostic Markers for Breast Cancer.

Varadi, Verena (2011) Single nucleotide polymorphisms in genes connected with chromosomal instability and their relation to breast cancer risk, tumour characteristics and survival - a search for breast cancer specific prognostic markers.

2010

Brandt, Andreas (2009) Analysis of the relationship between age and the risk of familial cancer.

Kunkel, Nelli (2009) Whole genome association study of familial colorectal cancer in the German population.

Weires, Marianne (2010) Estimating environmental effects in cancer development and mortality - methods and applications.

2009

Castro Duque, Felipe Andres (2009) Human leukocyte antigens and other genetic factors in cervical neoplasia.

Hiripi, Èva (2009) Familial aggregation of cancer in Swedish families with special reference to colorectal adenoma, gastro-intestinal carcinoid tumours and pancreatic cancer.

Ji, Jianguang (2008) Survival in common cancers is familial suggesting heritable causation - a population based study in Sweden.

Li, Xuchen (2008) Polymorphisms in transforming growth factor-beta 1 signaling pathway and epithelial-mesenchymal transition pathway with the risk of colorectal cancer.

2008

Brendle, Annika (2007) Genes in prolactin pathway and mitotic checkpoint as low penetrant risk factors for familial breast cancer.

2007

Pechlivanis, Sonali (2007) LOW-PENETRANCE SUSCEPTIBILITY GENES FOR COLORECTAL CANCER IN THE INSULIN/INSULIN GROWTH FACTOR 1 AXIS.

Wirtenberger, Michael (2007) Susceptibility genes for familial breast cancer.

2006

Wagner, Kerstin (2006) Search for breast cancer susceptibility genes in the growth hormone/insulin-like growth factor-1 axis.

2005

Rawal, Rajesh (2005) Familial risks of breast, ovarian and prostate cancers and the influence of diagnostic and screening methods.